Efficacy and safety of granulocyte–macrophage colony-stimulating factor (GM-CSF) antibodies in COVID-19 patients: a meta-analysis

OBJECTIVE: This study aims to determine the efficacy and safety of granulocyte–macrophage colony-stimulating factor (GM-CSF) antibodies in COVID-19 patients. METHODS: We searched Cochrane Library, PubMed, Embase, and ClinicalTrials.gov databases until July 27, 2022. Both randomized control trials (R...

Descripción completa

Detalles Bibliográficos
Autores principales: Xi, An-ran, Luo, Yi-jun, Guan, Jin-Tao, Wang, Wei-Jie, Xu, Zheng-Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707187/
https://www.ncbi.nlm.nih.gov/pubmed/36445552
http://dx.doi.org/10.1007/s10787-022-01105-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9707187/
https://www.ncbi.nlm.nih.gov/pubmed/36445552
http://dx.doi.org/10.1007/s10787-022-01105-9

Ejemplares similares